Celgene (CELG) Affirms $600M Acquisition of EngMab - Bloomberg, Citing Statement

September 30, 2016 12:37 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Celgene (Nasdaq: CELG) affirms earlier reports that it acquired EngMab for $600 million, according to Bloomberg, citing an emailed statement on Friday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Mergers and Acquisitions

Add Your Comment